Journal
ENDOCRINE REVIEWS
Volume 37, Issue 4, Pages 347-371Publisher
ENDOCRINE SOC
DOI: 10.1210/er.2015-1117
Keywords
-
Categories
Funding
- FWO Vlaanderen
- MRC [MC_UU_12012/5, MC_UU_12012/1] Funding Source: UKRI
- Medical Research Council [MC_UU_12012/1, MC_UU_12012/5] Funding Source: researchfish
- National Institute for Health Research [NF-SI-0507-10380, NF-SI-0513-10109] Funding Source: researchfish
Ask authors/readers for more resources
Prohormone convertase 1/3, encoded by the PCSK1 gene, is a serine endoprotease that is involved in the processing of a variety of proneuropeptides and prohormones. Humans who are homozygous or compound heterozygous for loss-of-function mutations in PCSK1 exhibit a variable and pleiotropic syndrome consisting of some or all of the following: obesity, malabsorptive diarrhea, hypogonadotropic hypogonadism, altered thyroid and adrenal function, and impaired regulation of plasma glucose levels in association with elevated circulating proinsulin-to-insulin ratio. Recently, more common variants in the PCSK1 gene have been found to be associated with alterations in body mass index, increased circulating proinsulin levels, and defects in glucose homeostasis. This review provides an overview of the endocrinopathies and other disorders observed in prohormone convertase 1/3-deficient patients, discusses the possible biochemical basis for these manifestations of the disease, and proposes a model whereby certain missense mutations in PCSK1 may result in proteins with a dominant negative action.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available